Latest Breaking News On - Kintor pharmaceuticals - Page 1 : comparemela.com

Basal Cell Carcinoma Pipeline, FDA Approvals, Clinical Trials Developments and Companies 2023 (Updated)

DelveInsight s, Basal Cell Carcinoma Pipeline Insight 2023 report provides comprehensive insights about 25+ Basal Cell Carcinoma companies and 25+ pipeline drugs in the Basal Cell Carcinoma pipeline.

Alopecia Treatment Market to Reach $14.16 Billion, Globally, by 2030 at 5.6% CAGR: Coherent Market Insights

Kintor Pharma Announces Completion of Patient Enrollment in Phase II Clinical Trial of KX-826 for Acne Vulgaris in China

/PRNewswire/ Kintor Pharmaceutical Limited ("Kintor Pharma", HKEX: 9939), a clinical-stage biotechnology company developing innovative small molecules and.

Kintor Scientists Published Results of Study Showing Pruxelutamide's Inhibitory Effects on Acute Lung Injury and Its Molecular Mechanism of Anti-Inflammatory Response

/PRNewswire/ Recently, Kintor Pharma scientists published results of a study titled " Inhibitory Effects of GT0918 on Acute Lung Injury and the Molecular.

Could Covid Drugs Help Cure Financial Ills At Ascletis Pharma? (undefined:ASCLF)

Ascletis Pharma (ASCLF) is ready to put its new Covid drug into clinical trials, but the firm is lagging in the race to bring similar medicines to market. Read more.